What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Dopamine
- Gene
Pier Vincenzo Piazza mainly focuses on Neuroscience, Addiction, Internal medicine, Endocrinology and Self-administration.
He specializes in Neuroscience, namely Neurogenesis.
His studies in Neurogenesis integrate themes in fields like Hippocampal formation, Hippocampus and Dentate gyrus.
His work deals with themes such as Amphetamine, Substance abuse and Pharmacology, Drug, which intersect with Addiction.
His Endocrinology research is multidisciplinary, relying on both Glutamatergic, Aggression and Endocannabinoid system.
The study incorporates disciplines such as Dopaminergic, Adrenalectomy and Glucocorticoid in addition to Corticosterone.
His most cited work include:
- Factors that predict individual vulnerability to amphetamine self-administration (1225 citations)
- Evidence for addiction-like behavior in the rat. (837 citations)
- Pathophysiological Basis of Vulnerability to Drug Abuse: Role of an Interaction Between Stress, Glucocorticoids, and Dopaminergic Neurons (609 citations)
What are the main themes of his work throughout his whole career to date?
Pier Vincenzo Piazza mainly investigates Internal medicine, Endocrinology, Neuroscience, Dopamine and Pharmacology.
His Endocrinology research incorporates themes from Receptor and Self-administration.
His study looks at the relationship between Neuroscience and topics such as Mechanism, which overlap with Memory impairment.
In his research, Antagonist is intimately related to Agonist, which falls under the overarching field of Dopamine.
His research investigates the connection between Pharmacology and topics such as Addiction that intersect with issues in Substance abuse and Mifepristone.
In his study, Transgene is inextricably linked to Dentate gyrus, which falls within the broad field of Neurogenesis.
He most often published in these fields:
- Internal medicine (51.82%)
- Endocrinology (51.36%)
- Neuroscience (51.82%)
What were the highlights of his more recent work (between 2013-2021)?
- Neuroscience (51.82%)
- Dopamine (34.55%)
- Pharmacology (29.09%)
In recent papers he was focusing on the following fields of study:
Pier Vincenzo Piazza focuses on Neuroscience, Dopamine, Pharmacology, Nucleus accumbens and Cannabinoid receptor.
He frequently studies issues relating to Endocannabinoid system and Neuroscience.
The Dopamine study combines topics in areas such as Glucocorticoid receptor, Neuron and 5-HT receptor.
His Pharmacology research includes themes of Agonist and Pregnenolone.
Pier Vincenzo Piazza focuses mostly in the field of Dentate gyrus, narrowing it down to topics relating to Transgene and, in certain cases, Neurogenesis.
In his research on the topic of SB-242084, Endocrinology is strongly related with Neurotransmission.
Between 2013 and 2021, his most popular works were:
- Pregnenolone Can Protect the Brain from Cannabis Intoxication (181 citations)
- Pregnenolone Can Protect the Brain from Cannabis Intoxication (181 citations)
- Cannabinoid control of brain bioenergetics: Exploring the subcellular localization of the CB1 receptor (76 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Dopamine
The scientist’s investigation covers issues in Cannabinoid, Cannabinoid receptor, Neuroscience, Receptor and Mitochondrion.
His Cannabinoid research integrates issues from Antagonist, Subcellular localization, Catalepsy and Rimonabant.
His studies deal with areas such as Endocannabinoid system and Effector as well as Neuroscience.
His study ties his expertise on Pharmacology together with the subject of Receptor.
His Pharmacology research is multidisciplinary, relying on both Paracrine signalling, Autocrine signalling and Hormone, Steroid, Pregnenolone.
His Mitochondrion study incorporates themes from Carbohydrate metabolism, Premovement neuronal activity, Neurotransmitter and Metabolism.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
